PT-141 (Bremelanotide) Protocol
PT-141 (Bremelanotide) dosing protocol — the melanocortin peptide for sexual-health research.
What it is and why it matters
PT-141 (Bremelanotide) is presented here as a descriptive reference, not just a dosing card. The point is to explain the biological lane it belongs to, what kind of signal it may be carrying, and why people pay attention to it in the first place.
For a general reader, that means the page should read like a small guide to the system behind the peptide: what it touches, what people hope it might do, and what part of the schedule helps make sense of the result.
How to mix and measure it
Start with the vial label and the BAC amount you plan to use. The same peptide name can describe different fills, and concentration is what makes the dose schedule legible.
The calculator is a translation layer: it turns the raw bottle math into a unit draw that matches the actual product in your hands.
What the schedule looks like
| Period | Dose | Units (@ 3.33 mg/mL) | Frequency |
|---|---|---|---|
| Weeks 1–8 | 500 mcg (0.5 mg) | 15 units (0.15 mL) | 1x/day |
| Weeks 9–12 | 1,000 mcg (1.0 mg) | 30 units (0.30 mL) | 1x/day |
| Weeks 13–16 | 1,500 mcg (1.5 mg) | 45 units (0.45 mL) | 1x/day |
For PT-141 (Bremelanotide), the schedule is the bridge between the biology and the real-world draw amount. Read it as a pattern over time, not as a one-line summary of the compound.
How long people usually use it
A finite window usually makes more sense than an open-ended routine. It gives the reader a clean before-and-after frame and keeps the page anchored to something the body can actually respond to.
Why this page exists
Note for readers: this page expands the source material into a plain-language guide. It is meant to explain what the peptide is, why people study it, and how the schedule should be read.
The goal is to give readers the full picture without making them wade through jargon.